Journal article

Biomarkers and surrogate endpoints.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Aronson, J. (2005). Biomarkers and surrogate endpoints. British Journal of Clinical Pharmacology, 59(5), 491–494.

MLA Style

Aronson, J. “Biomarkers and Surrogate Endpoints.” British Journal of Clinical Pharmacology, vol. 59, no. 5, 2005, pp. 491–94.

Chicago Style

Aronson, J. 2005. “Biomarkers and Surrogate Endpoints.” British Journal of Clinical Pharmacology 59 (5): 491–94.
Print

Access Document

Publisher copy:: 10.1111/j.1365-2125.2005.02435.x

Authors

+ Aronson, J More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Primary Care Health Sciences
Role:: Author

Journal:: British journal of clinical pharmacology More from this journal
Volume:: 59
Issue:: 5
Pages:: 491-494
Publication date:: 2005-05-01
DOI:: 10.1111/j.1365-2125.2005.02435.x
EISSN:: 1365-2125
ISSN:: 0306-5251

Language:: English
Keywords:: Humans

Biological Markers

Costs and Cost Analysis
Pubs id:: pubs:117041
UUID:: uuid:4e7367ca-791f-413d-bec7-0a147746e130
Local pid:: pubs:117041
Source identifiers:: 117041
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_4e7367ca791f413dbec70a147746e130

Terms of use

Copyright date:: 2005

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP